debulking surgery Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)

Phase 2 (1)

Interventional (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadmetastasis

I am/have/hadblood transfusion

I am/have/hadhysterectomy

I am/have/hadcervical cancer

I am/have/hadnon-melanoma skin cancer

I am/have/hadprimary peritoneal carcinoma

I am/have/haddebulking surgery

I am/have/hadfallopian tube

I am/have/hadmaintenance treatment

I am/have/hadperitoneal cancer

I am/have/hadskin cancer

I am/have/hadplatelet count

I am/have/hadsterilisation

I am/have/hadestimated creatinine clearance

I am/have/hadliver metastasis

I am/have/hadoophorectomy

I am/have/hadwhite blood cell count

I am/have/hadtreatment and maintenance

I am/have/hadskin carcinoma

added new label for I am/have/had

more

I am looking for

I am looking formelanoma

I am looking forcarboplatin

I am looking forolaparib

I am looking forparp inhibitor

I am looking foradp-ribose

I am looking forfollicle stimulating hormone

I am looking forluteinizing hormone

I am looking forpaclitaxel

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Recruiting

NUVOLA TRIAL Open-label Multicentre Study

Nonetheless, BRCAmut women additionally show a higher benefit of platinum-based neoadjuvant chemotherapy (NACT) plus interval debulking surgery compared with BRCAwt women in terms of clinical and pathological responses, suggesting that BRCA mutational status might be used as a molecular tool to personalize treatment in high-grade serous ovarian cancer (HGSOC) patients.

measurable disease

melanoma

olaparib

metastasis

blood transfusion

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.